Download FREE Report Sample
Download Free sampleVaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
Conjugate Vaccine Market contains market size and forecasts of Conjugate Vaccine in global, including the following market information:
Global Conjugate Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Conjugate Vaccine Market Sales, 2017-2022, 2023-2028, (Million Unit)
Global top five Conjugate Vaccine companies in 2021 (%)
The global Conjugate Vaccine market was valued at 10280 million in 2021 and is projected to reach US$ 12700 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hib Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Conjugate Vaccine include Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Bharat Biotech and Zhifei Biologic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Conjugate Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Conjugate Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Million Unit)
Global Conjugate Vaccine Market Segment Percentages, by Type, 2021 (%)
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Global Conjugate Vaccine Market, by End Users, 2017-2022, 2023-2028 ($ Millions) & (Million Unit)
Global Conjugate Vaccine Market Segment Percentages, by End Users, 2021 (%)
Children
Adult
Global Conjugate Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Million Unit)
Global Conjugate Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Conjugate Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Conjugate Vaccine revenues share in global market, 2021 (%)
Key companies Conjugate Vaccine sales in global market, 2017-2022 (Estimated), (Million Unit)
Key companies Conjugate Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
